Current stock page

Financial Data

LNTH Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareDrug Manufacturers - Specialty & GenericScore data as of Sep 4, 2026

LNTH

Financial Data
Lantheus Holdings, Inc.
Healthcare· Drug Manufacturers - Specialty & Generic
AIQ Score
NeutralAIQ Edge 9/10
Relative Leader / Watch
Strong Relative Position
Score data as of Sep 4, 2026
Last price
$100.97
-$0.01 (-0.01%)
Latest market quote
Momentum50
Value53
Quality73
Risk Resilience69
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 7, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$388.18M$377.33M$406.79M$384.01M$378.05M$372.76M$391.11M$378.73M
Gross Profit$241.86M$230.92M$240.88M$222.37M$241.01M$237.7M$248.55M$242.13M
Operating Income
Net Income$75.03M$118.42M$54.09M$27.77M$78.76M$72.95M-$11.79M$131.09M
EPS$1.15$1.83$0.82$0.41$1.15$1.06-$0.17$1.89
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow$217.33M$125.13M$90.18M$105.29M$87.11M$107.56M$155.4M$175.06M
Capital Expenditure-$5.56M-$3.23M-$8.79M-$10.62M-$13.37M-$8.72M-$16.37M-$15.81M
Free Cash Flow$211.77M$121.9M$81.39M$94.67M$73.73M$98.85M$139.03M$159.25M
Net Cash Provided By Operating Activities$217.33M$125.13M$90.18M$105.29M$87.11M$107.56M$155.4M$175.06M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$2.41B$2.35B$2.23B$2.28B$2.12B$2.06B$1.98B$2.05B
Total Debt$624.96M$625.75M$673.25M$619.44M$615.49M$614.4M$619.44M$619.24M
Cash And Cash Equivalents
Total Liabilities$1.1B$1.13B$1.14B$1.16B$949.29M$891.03M$892.33M$869.92M
Total Stockholders Equity$1.31B$1.21B$1.09B$1.12B$1.17B$1.16B$1.09B$1.18B
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio24.1210.3620.2931.0417.822.97-131.314.54
P/B ratio5.514.0543.084.815.765.696.46
P/S ratio18.6213.0110.738.9814.8417.9815.8320.13
Debt To Equity0.480.520.620.550.530.530.570.52
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio5.514.0543.084.815.765.696.46
P/S ratio18.6213.0110.738.9814.8417.9815.8320.13
Return On Equity5.72%9.77%4.96%2.48%6.75%6.27%-1.08%11.11%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
23.96
multipleSep 4, 2026
Pb
5.01
multipleSep 4, 2026
Revenue Growth Yoy
2.87
percentSep 4, 2026
EPS Growth Yoy
-37.16
percentSep 4, 2026
Gross Margin
60.14
percentSep 4, 2026
Operating Margin
19.43
percentSep 4, 2026
ROE
23.27
percentSep 4, 2026
ROIC
11.03
percentSep 4, 2026
Debt To Equity
0.48
ratioSep 4, 2026
FCF Yield
7.76
percentSep 4, 2026
Technical indicators
Close
100.97
priceSep 4, 2026
Volume
859,896
volumeSep 4, 2026
Rsi14
50.86
indexSep 4, 2026
MACD
-0.38
indexSep 4, 2026
MACD Signal
-0.55
indexSep 4, 2026
MACD Histogram
0.17
indexSep 4, 2026
Adx14
9.9
indexSep 4, 2026
Sma50
103.11
priceSep 4, 2026
Sma200
84.22
priceSep 4, 2026
Atr14
1.05
priceSep 4, 2026
Historical Volatility
0.05
percentSep 4, 2026
Volume Ma20
1,394,564.15
volumeSep 4, 2026
Risk measures
Resilience Score
69
score_0_100Sep 4, 2026
Beta
-0.06
ratioSep 4, 2026
Volatility Annual
35.16
percentSep 4, 2026
Max Drawdown
-12.17
percentSep 4, 2026
Sharpe Ratio
1.86
ratioSep 4, 2026
Var95
-2.85
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

LNTH Financial Data FAQ

What is Lantheus Holdings, Inc.'s revenue?

Lantheus Holdings, Inc.'s revenue is one of the core financial data points for LNTH. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Lantheus Holdings, Inc.'s revenue growing?

Revenue growth shows whether Lantheus Holdings, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is LNTH's EPS?

LNTH's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Lantheus Holdings, Inc.'s net income?

Lantheus Holdings, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Lantheus Holdings, Inc. generate?

Free cash flow shows how much cash Lantheus Holdings, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Lantheus Holdings, Inc. have?

Cash and debt help frame LNTH's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.